ADHD: Clinical Trials

2 trials for ADHD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 2

Follow ADHD: new trials by email Literature Review of ADHD trials Research Report on ADHD

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder
Delayed-release, extended-release methylphenidate, Placebo - ADHD, Cannabis Use Disorder
Phase 4Not yet recruitingMassachusetts General Hospital662026-11-012026-09-28
EEG Biomarkers for ADHD Stimulant Treatment
methylphenidate HCl, Mixed amphetamine salts extended release - ADHD
Phase 4Not yet recruitingBoston Children's Hospital2202026-09-152026-06-16

Narrower conditions

Attention Deficit Disorder with Hyperactivity (2)  ·  Marijuana Abuse (1)  ·  Substance-Related Disorders (1)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (2)  ·  Mental Disorders (2)  ·  Neurodevelopmental Disorders (2)  ·  Chemically-Induced Disorders (1)

Interventions

Methylphenidate (2)

Sponsors

Boston Children's Hospital (1)  ·  Massachusetts General Hospital (1)

Countries

United States (2)

NIH funding

K12DA000357 (1)